Optomed Plc Stock Exchange Release 12 March 2021 at 9.00, Helsinki
Optomed Annual Report 2020 published
Optomed's Annual Report 2020 has been published. The Annual Report includes the company's consolidated and parent company financial statements, the report of the board of directors, corporate governance statement and remuneration report for governing bodies.
Optomed publishes its financial statements in accordance with the European Single Electronic Format (ESEF) reporting requirements. As per ESEF requirements, the primary statements have been labelled with XBRL tags, which have been verified by the Company’s auditor.
The Annual Report is attached to this release as a PDF file and it is available in English and Finnish on the corporate website www.optomed.com/investors/. The financial statements are attached as an XHTML file.
Optomed Plc
Further enquiries
Lars Lindqvist, CFO, Optomed Plc, lars.lindqvist@optomed.com
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 565 international patents protecting the technology.
